Merck & Co., Inc. (MRK) Cuts Another 600 Sales Reps
Bristol-Myers Squibb Company (BMY) Taps Bay Area's Redwood City For Expansion, Pharma Giant To Increase Workforce
Bruker Corporation Discloses Plans To Sell California Unit And Lay Off Up To 250 Staffers
Reckitt Benckiser Plc (RB.L) To Invest €100 Million In Its Consumer Health R&D Operations, Will Create 1,200 New Jobs
New Cambridge-Based Biotech VC Firm Remiges BioPharma Emerges, Eyes $150 Million Fund
GlaxoSmithKline (GSK) Seeks Approval For First Ever Malaria Vaccination
Amgen (AMGN), Bayer HealthCare (BAY)'s Nexavar Fails Late-Stage Breast Cancer Study
Massachusett's Ocular Therapeutix, Inc. (OCUL) Goes IPO At $13 A Share
Sources Reveal Reckitt Benckiser Plc (RB.L) Plans To Spinoff Virginia-Based Pharmaceutical Unit
Allegations Of GlaxoSmithKline (GSK) Corruption Spread To Syria
Kidney Dialysis Drug Phase 3 Data Boost Keryx Biopharmaceuticals (KERX)'s Hopes For U.S. Approval
Merck KGaA (MKGAF.PK) Eyes Southeast Asia Plants To Cut Costs
Merck KGaA (MKGAF.PK) To Begin Construction Of $108 Million China Plant
Incyte Corporation (INCY)'s Jakafi Fails to Provide RELIEF In Phase 3 Trial
AgeneBio Appoints Industry Leaders Patrick Lepore As Chairman Of The Board And Jerry Mclaughlin As President And Chief Executive Officer
Amgen (AMGN) Nervous As FDA Paves Way For Novartis AG (NVS) To Copy Drug Neupogen
Sarepta Therapeutics (SRPT) Terminates Chief Science Officer As It Heads Toward Drug Approval
Study Claims Celgene (CELG) Drug Can Drive HIV Out Of Hiding
See All News >
//-->